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Abstract 
 
Background: As a bioactive composite extracted from American cockroach, Xinmailong injection (XML) is used for the 
treatment of congestive heart failure (CHF) in China. Clinical data has provided evidence that XML has positive inotropic 
properties. The objective of this study was to assess the mechanisms involved in the therapeutical effect of XML on CHF. 
Materials and Methods: The effects of XML on the cardiac function in isolated rat heart were measured. A Ca
2+
 imaging 
technology was used in rat cardiomyocytes (H9c2 cells) to reveal the role of XML on Ca
2+
 channels. Meanwhile, the effects of 
XML on the activities of Na
+
/K
+
 ATPase and sodium/calcium exchanger were measured. In addition, the level of reactive 
oxygen species and the protein expressions for the superoxide dismutase and hemeoxygenase were determined in the 
cardiomyocytes. 
Results: The results showed that XML increased the electrical impulse-induced [Ca
2+
]i in H9c2 cells, which was dependant on 
extracellular Ca
2+
 and was abolished by ML218-HCl (a T-type Ca
2+
channels antagonist) but not nimodipine (a L-type 
Ca
2+
channels antagonist). Ouabain, a Na
+
/K
+
-ATPase inhibitor, increased the electrical impulse-induced [Ca
2+
]i, which was  
significantly inhibited by XML. Moreover, XML markedly inhibited the Na+/K+ ATPase activity in H9c2 cells. In addition, 
XML notably reduced the production of reactive oxygen species and enhanced the protein expressions of antioxidant 
enzymes including superoxide dismutase 1, superoxide dismutase 2 and hemeoxygenase 1 in H9c2 cell.  
Conclusion: Our findings pave the ways to the better understandings of the therapeutic effects of XML on cardiovascular 
system.  
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Introduction  
         
Clinically, congestive heart failure (CHF) is defined as a complex syndrome where the heart is incapable of maintaining 
the cardiac output that is adequate to meet metabolic requirements and accommodate venous return (Yancy et al., 2013). This 
structural or functional impairment of ventricular filling or ejection of blood always causes the fluid retention, such as the 
pulmonary and/or splanchnic congestion and/or peripheral edema (Yancy et al., 2013). Probably due to the increased aging 
population and the incidence of risk factors such as ischemic heart diseases and hypertension, the CHF prevalence has kept 
rising and is estimated to increase 46% from 2012 to 2030 (Bui et al., 2011; Khatibzadeh et al., 2013; Mozaffarian et al., 2015). 
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Without doubt, CHF will continue to be a substantial burden on health-care systems and societies. Therefore, more effective 
medications with low side effects and low cost are required to improve the survival in patients with CHF.   
In the present, the treatment of CHF is frequently based on the western medicine, which include β-receptor blockers, 
diuretics and renin-angiotensin-aldosteronesystem antagonists. In addition, some novel anti-CHF drugs such as lyophiluzed 
recombinant human brain natriuretic, levosimendan, ivabradine, tolvaptan and istaroxime are also used to treat CHF (Karl et al., 
2015). Traditional Chinese Medicine (TCM) practices represent a healthy complement to practices. Since 2006, a number of 
TCMs were clinically tested on the CHF patients and exciting therapeutic effects were achieved (Chen et al., 2010; Miao et al., 
2008). Cockroach has been described as an effective insect drug which can promote blood circulation and urination in Bencao 
Gangmu (Compendium of Materia Medica) in the Ming Dynasty by Li Shizhen, a well-known medical specialist and 
pharmacologist of ancient China. Xinmailong Injection (XML), a compound extracted from Periplaneta Americana (P. 
americana, also known as American cockroach), has been launched to market in China as a proprietary medication for treating 
patients with CHF (Ma et al., 2013). The major bioactive ingredients of P. americana include polypeptides, nucleosides and 
amino acids (He et al., 2008). Although it is highly effective, the mechanisms underlying the action of XML in the treatment of 
heart failure are rarely investigated. Therefore, the present study was designed to verify the mechanisms underlying the 
enhancive effects of XML on cardiac functions. Focus was put on studying the mechanism leading to the increase of [Ca
2+
]i in 
cardiomyocytes. In addition, since oxidative stress is an important factor that deteriorates the functions of cardiomyocytes and is 
involved in the pathophysiology of CHF (Tsutsui et al., 2011), the antioxidant effect of XML on cardiomyocytes was also 
investigated. 
 
Materials and Methods 
Chemicals and drugs 
 
XML (Lot.:120228) was provided by Tengyao Pharmaceutical Company Limited by Shares Yunnan. Ouabain, Bay K8644, 
Nimodipine, Thapsigargin and KBr7943 were purchased from Sigma Aldrich Inc. (St. Louis, MO, USA). ML218-HCl was 
obtained from Tocris Bioscience (Tocris, Bristol, UK). The other reagents were of analytical purity. 
 
Animals 
 
Male Sprague-Dawley rats (250-300 g) were supplied from the Laboratory Animal Unit of Kunming Medical University 
(Kunming, China). All experiments performed in this study were approved by the Committee on the Use of Live Animals in 
Teaching and Research of Yunnan Minzu University. 
 
Perfusion of hearts 
 
In vitro heart perfusion was performed as described
 
(Mishra et al., 2014). Briefly, rats were injected intraperitoneally with 
sodium pentobarbital (50 mg/kg, i.p.) to induce anesthesia, and then sacriﬁced by cervical dislocation. Following excision and 
cleaning, hearts were mounted on a blunted 16-gauge needle of a Langendorff apparatus (GL-1, Chengdu TME Technology, 
Chengdu, China) and perfused retrogradely through the ascending aorta under constant pressure with oxygenated (95% O2/5% 
CO2) Krebs buffer maintained at 37℃. The coronary ﬂow rate was monitored via a Doppler ﬂow probe (0.5-mm id; Transonic 
Systems, Ithaca, NY, USA) and a Transonic T206 ﬂow meter (Transonic Systems). Iso-volumetric left ventricular developed 
pressure was measured with a ﬂuid-ﬁlled latex balloon inserted into the left ventricle via the left atrium and connected to a 
pressure transducer (BL-420F, Chengdu TME Technology, Chengdu, China). Accumulative concentrations of XML (0.1, 0.5, 
1.0, 2.0 mg/mL) were added to the Krebs buffer to determine the effect of XML on the heart rates, the coronary ﬂow rates, the 
left ventricular systolic pressure (LVSP), the left ventricular end-diastolic pressure (LVEDP) and the left ventricular pressure 
maximum rise/fall rate changes (±dP/dt max). 
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Cell culture 
 
H9c2, a cell line derived from embryonic BD1X rat heart tissue, was purchased from American Type Culture Collection 
(CRL-1446, ATCC, Manassas, VA). Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (Gibco, Invitrogen, 
Carlsbad, CA, USA) with 10% (v/v) fetal bovine serum (FBS) (Gibco, Invitrogen, Carlsbad, CA, USA), 100 units/ml penicillin 
and 100 µg/ml streptomycin (P/S) (Gibco, Invitrogen, Carlsbad, CA, USA). Cells were incubated in 37℃ with 5% CO2/95% air 
(Napco, Thermo Fisher Scientific, MA, USA). Medium was changed every two days and cells were subjected to subculture 
when 95% of confluence was reached. Cells were sub-cultured to 6-well plates or 24-well plates. 
 
Ca
2+ 
imaging 
 
H9c2 cells were seeded on round covered lip pre-coated with poly-D-lysine inside 24 well-plates. Prior to Ca
2+ 
imaging 
study, culture medium was removed and the cells were rinsed twice with HEPES buffered Hanks’ balanced salt solution 
(HEPES-HBSS) containing CaCl2 (1.8 mM) and MgCl2 (0.8 mM), pH 7.4. Cells were then incubated with 2 μM Fura-2 AM 
(Invitrogen, Carlsbad, CA, USA) and 1% (v/v) bovine serum albumin for 60 min at room temperature. After dye loading, the 
covers lip was mounted in an open bath imaging chambers (RC-21B, Warner Instruments, Connecticut, USA) and visualized 
under a Nikon Eclipse Ti microscope (Nikon, Tokyo, Japan) using a 20× objective (Nikon CFIS Fluor Objective). Cells were 
then continuously superfused with HEPES-HBSS. Fura-2 AM was alternately excited at 340 and 380 nm, and the emitted 
fluorescence filtered at 510 nm was recorded by a SPOT RT3 CCD digital microscope camera (SPOT Imaging Solutions, 
Michigan, USA) every 5s controlled by Meta Fluor Imaging Software (Molecular Devices, CA, USA). The 340/380 ratio 
reflects the change of intracellular free Ca
2+
. An electrical stimulator (S48 Square Pulse Stimulator, GRASS, Technologies) was 
used to trigger the depolarization of cell membrane. Cells were stimulated with a stimulation rate of 1/s, pulse delay time of 
0.01 ms, pulse duration of 40 ms and voltage of 150 V. 
For the experiment with electrical stimulation, H9c2 cells were incubated with XML (Tengyao, Yunnan, China), ouabain 
(Sigma, O3125, St. Louis, MO) or Bay K8644 (Sigma, B112, St. Louis, MO) for 30 min at 37℃ before Ca2+ imaging. 
Nimodipine (Sigma, M3764, St. Louis, MO) or ML218-HCl (Tocris, 4507, Bristol, UK) was added to chamber just before the 
start of the Ca
2+ 
imaging and the cells was incubated with these drugs for at least 5 min at room temperature. For the experiment 
without electrical stimulation, thapsigargin (Sigma, St. Louis, MO), ouabain (Sigma, St. Louis, MO) and KBr7943 (Sigma, St. 
Louis, MO) was added during Ca
2+
 imaging. 
 
Protein Extraction and Western Blotting Analysis 
 
H9c2 cells were incubated without (Control) or with XML for 24 h. Cells were then washed three times with ice-cold PBS 
and lysed in lysis buffer with protease inhibitor cocktail for 15 min. Cell lysates were homogenized and supernatant was 
collected by centrifugation at 18,000 g for 10 min at 4℃. Protein concentration was determined by Bio-Rad Bradford Assays 
using bovine serum albumin as standard. Protein samples were mixed with SDS-reducing buffer (final concentration of 2% SDS, 
5% 2-mercaptoethanol, 10% glycerol, 0.002% bromophenol blue, 0.0625 M Tris-HCl, pH 6.8) and denatured at 100℃ for 10 
min, and then subjected to electrophoresis (SDS-PAGE) with 12% SDS-polyacrylamide gel under 150 V for 2 h and transferred 
to PVDF membrane under 100 V for 2h. The membrane was blocked by 5% non-fat milk (in TBS containing 0.2% Tween-20, 
150 mM NaCl, 50 mM Tris-HCl, pH 7.6, TBST) for 2 h at room temperature. The membrane was then incubated with 
anti-superoxide dismutase-1 (SOD-1) (Santa Cruz, CA, USA), anti-SOD2 (Santa Cruz, CA, USA) or anti-hemeoxygenase-1 
(HO-1) (Santa Cruz, CA, USA) antibody at 4℃ overnight. The concentration of primary antibody used was 1:500 (v/v). β-actin 
was used as internal control. After incubation of primary antibody, the membrane was washed three times with TBST for 10 min 
at room temperature. This is followed by immunoblotting with horseradish peroxidase-conjugated goat-anti-rabbit secondary 
antibody (BioRad, 170-6515, CA, USA) or with horseradish peroxidase (HRP)-conjugated goat-anti-mouse secondary 
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antibodies (BioRad, 172-1011, CA, USA) at room temperature for 2 h. The concentration of secondary antibodies used was 
1:10000 (v/v). The membrane was washed 3 times again with TBST for 10 min at room temperature, and followed by 
incubation with HRP substrate (Millipore, WBKLS0500, Billerica, USA) for 1 min at room temperature. The 
chemiluminescence emitted was captured by X-ray film (Fujifilm, Tokyo, Japan) with appropriate exposure time. 
 
Measurement of Na
+
/K
+
 ATPase Activity 
 
The effect of XML on Na
+
/K
+
-ATPase activity was measured using the previous protocol (Fuller et al., 2003). H9c2 cells 
were homogenized by buffer A (20 mM HEPES, 250 mM sucrose, 2 mM EDTA, 1 mM MgCI2, pH 7.4) and centrifuged at 
20,000 g for 30 min. The supernatant was discarded and the pellet was resuspended in buffer A. The amount of protein was 
pre-determined by Bio-Rad Bradford Assays (Bio-Rad, 500-0001, CA, USA). Two 50 μl aliquots of homogenate were taken. 
One aliquote was mixed with 50 μl of reaction buffer 1 (200 mM Tris-HCl, 30 mM MgCl2, 200 mM NaCl, 60 mM KCl, 10 mM 
EGTA, pH 7.5). Another one was mixed with reaction buffer 2 (buffer 1 + 1 mM ouabain). Each reaction contained 100 µg/mL 
PMSF, 2 µg/mL apronitin and 2 µg/mL pepstatin A to prevent protein degradation. The reaction was started by the addition of 1 
mM of ATP. Reactions proceeded for 10 min at 37℃ and 10 µL of 100% (w/v) trichloroacetic acid were added to stop the 
reaction. Samples were left on ice for 1 h and then centrifuged at 20,000 g for 30 min to pellet the precipitated protein. Free 
phosphate in supernatant was assayed using the ammonium molybdate spectrophotometric assay kit (Sigma, MAK030, St. 
Louis, MO). The absorbance at 650 nm was measured. 
 
Measurement of Intracellular Reactive Oxygen Species 
 
H9c2 cells were cultured in black 96 well-plates without (as Control) or with XML for 4 h at 37℃. OxiSelectTM 
intracellular ROS assay kit (green fluorescence) (Cell Biolabs, STA342, San Diego, CA, USA) was used to determine the ROS 
in the samples by using DCFH-DA as a probe. DCF standard curve was constructed according to the manufacturer’s instruction. 
Before the experiments, the sample was washed once with HEPES-HBSS, followed by incubation with 1 mM DCFH-DA at 
37℃ for 1h. Afterwards, the sample was washed by HEPES-HBSS once again to remove the unloaded DCFH-DA. The plate 
was then placed in a microplate reader to measure the fluorescence (emission at 480 nm and excitation at 530nm). 
 
Statistical Analyses 
 
All data were expressed as means ± S.E.M. Statistical analyses were performed using SPSS 22.0. Comparison between two 
groups was analyzed using Student’s t-test. Comparison among three or more groups was analyzed using one-way ANOVA, 
p<0.05 was considered statistically signiﬁcant. 
 
Results 
Effect of XML on Cardiac Function 
 
As demonstrated in Fig 1A-C, XML significantly increased the coronary blood flow, LVSP, LVEDP and ±dp/dt max of the 
hearts in a dose-dependent manner. In contrast, the heart rates were mildly decreased (10.57±2.10%) after treatment with XML 
(Fig 1D). 
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Figure 1: Effects of XML on the cardiac functions in rats. In vitro heart perfusion was performed by using a Langendorff 
apparatus. Accumulative concentrations of XML (0.1, 0.5, 1.0, 2.0 mg/ml) were added to the perfusion buffer. (A) Effect of 
XML on the coronary ﬂow rates. (B) Effect of XML on the left ventricular systolic pressure (LVSP) and the left ventricular 
end-diastolic pressure (LVEDP). (C) Effect of XML on the left ventricular pressure maximum rise/fall rate changes (±dP/dt 
max). (D) Effect of XML on the heart rates. Values are means ± S.E.M. (n = 5). 
 
Effect of XML on [Ca
2+
]i of H9c2 under electrical stimulation 
 
XML elevated the electrical pulse-induced [Ca
2+
]i in H9c2 cells (Fig 2A). The effect of XML was concentration-dependent 
with an EC50 value of about 0.5 mg/ml. The threshold concentration of XML was 0.01 mg/ml and the effect of XML was 
leveled off at 10mg/ml (Fig 2B). 
 
Effect of XML on Ca
2+ 
influx and intracellular store of Ca
2+
 
 
To study the effect of XML on Ca
2+
 influx, Ca
2+
 was measured with the use of Ca
2+
 free solution as bathing solution. When 
Ca
2+
 was absent in the bathing solution, the electrical stimulation could not induce any elevation of [Ca
2+
]i
 
regardless any 
concentration of XML (Fig 2C). 
To study the effect of XML on Ca
2+ 
release from intracellular store, thapsigargin (TG, 1 µM), an apotent sacroplasmic 
reticulum Ca
2+
 ATPase (SERCA) inhibitor which depletes Ca
2+ 
stores in sacroplasmic reticulum and endoplasmic reticulum by 
blocking Ca
2+ 
uptake and allows Ca
2+
 to passively leak out, was added to H9c2 cells. TG induced a transient increase in [Ca
2+
]i. 
However, there was no significant difference between the Control and XML-treated cells (Fig 2D). 
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Figure 2: Effect of XML on the [Ca
2+
]i. Ca
2+
 was measured by Ca
2+
 imaging with the use of Fura-2 AM. (A) Effect of XML on 
the electrical impulse-induced [Ca
2+
]i of H9c2 cells. Cells were incubated with different concentration XML (from 0 to 5 mg/ml) 
for 30 mins before stimulation with electrical impulse. (B) Concentration-response relationship of XML on the electrical 
impulse-induced Ca
2+
 in H9c2 cells. (C) Effect of XML on the electrical impulse-induced [Ca
2+
]i in H9c2 cells measured under 
extracellular Ca
2+
-free condition. (D) Effect of XML on the thapsigargin-induced [Ca
2+
]i in H9c2 cells. Thapsigargin is an 
apotent SERCA inhibitor which depletes Ca
2+ 
stores in sacroplasmic reticulum and endoplasmic reticulum by blocking Ca
2+ 
uptake via SERCA and allows Ca
2+
 to passively leak out. (E) Effect of XML on the L-type Ca
2+
 channels in H9c2 cells. 
Nimodipine (20 µM), an L-type Ca
2+ 
channels antagonist. BayK8644 (10 µM), an L-type Ca
2+ 
channels agonist. (F) Effect of 
XML on the T-type Ca
2+
channels in H9c2 cells. ML218-HCl (100 µM), a T-type Ca
2+ 
channels antagonist. Values are expressed 
as mean ± S.E.M. (n = 5). *P< 0.05, **P< 0.01, compared with Control. 
 
Effect of XML on T-type Ca
2+
channels 
 
Nimodipine (20 µM), an L-type Ca
2+
channels antagonist, abolished the electrical impulse-induced [Ca
2+
]i increase
 
(Fig 2E). 
BayK8644 (10 µM), a L-type Ca
2+ 
channels agonist, potentiated the electrical impulse-induced [Ca
2+
]i increase
 
which was 
completely inhibited by nimodipine (20 µM). The effect of XML on electrical impulse-induced [Ca
2+
]i increase was not affected 
by nimodipine, but was abolished by ML218-HCl (100 µM), a T-type Ca
2+
channels antagonist (Fig 2F). 
 
 
Effect of XML on sodium/calcium exchanger (NCX) and Na
+
/K
+
-ATPase 
 
To investigate the effects of XML on NCX, KB-r7943 (10 µM) was used. As an inhibitor of NCX KB-r7943 reverses the 
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mode of exchanger so that Ca
2+
 is transported into cells while Na
+
 is transported out of cell. KB-r7943 induced an increase in 
Ca
2+
 in H9c2 cells even without electrical stimulation (Fig 3A). Unlike KB-r7943, XML (0.05 mg/ml and 0.5 mg/ml) could not 
increase the Ca
2+ 
in H9c2 cells if no electrical stimulation was used. 
Ouabain (10 µM), a potent Na
+
/K
+
 ATPase inhibitor, was used to study any involvement of Na
+
/K
+
ATPase in the effect of 
XML. Ouabain did not affect the [Ca
2+
]i in H9c2 cells without electrical stimulation (Fig 3B). Under the electrical stimulation 
ouabain (1 mM, the concentration that produced maximum effect) had no additive effect on XML-induced [Ca
2+
]i
 
increase but 
XML significantly inhibited the [Ca
2+
]i
 
increase induced by ouabain (Fig 3C), suggesting the overlapping of the action site of 
ouabain and XML. Further study was carried out to investigate the effect of XML on the activity of Na
+
/K
+
 ATPase. Na
+
/K
+
 
ATPase activity was also markedly inhibited after cells were treated with XML (Fig 3D). 
 
 
Figure 3: Effect of XML on sodium/calcium exchanger and Na
+
/K
+
-ATPase. (A) Effect of XML on the sodium/calcium 
exchanger in H9c2 cells. KB-r7943 (10 µM), an inhibitor of sodium/calcium exchanger. (B) Effect of oubain and XML on the 
[Ca
2+
]i of H9c2 cells without electrical stimulation. Ouabain (10 µM), a potent Na
+
/K
+
 ATPase inhibitor. (C) Effect of XML on 
the ouabain-induced [Ca
2+
]i increase in H9c2 cells. (D) Effect of XML on the Na
+
/ K
+
-ATPase activity in H9c2 cells. Effect of 
ouabain and XML on the [Ca
2+
]i of H9c2 cells without electrical stimulation. Values are means ± S.E.M. (n = 5). *P< 0.05, 
**P< 0.01, compared with Control. 
 
Antioxidant effect of XML 
 
H9c2 cells were incubated without (Control) or with 1 mg/ml of XML for 4 h at 37℃. Western blotting was performed to 
detect the changes in the protein expression levels of SOD-1 (Fig 4A and B), SOD-2 (Fig 4C and D) and HO-1 (Fig 4E and F). 
The results showed that the protein expressions of these antioxidant enzymes in H9c2 cells were elevated after treatment with 
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XML (1 mg/mL). H2O2 increased the DCF fluorescent signal and the fluorescence was significantly decreased by 0.5 mg/mL of 
XML (Fig 4G). 
 
Figure 4: Antioxidant effect of XML. (A) Effect of XML on the protein expression of superoxide dismutase-1 (SOD-1) in 
H9c2 cells. (B) Averaged densitometric quantiﬁcation of SOD-1 protein levels. β-actin served as a loading control. (C) Effect of 
XML on protein expression of SOD-2 in H9c2 cells. (D) Averaged densitometric quantiﬁcation of SOD-2 protein levels. β-actin 
served as a loading control. (E) Effect of XML on protein expression of hemeoxygenase-1 (HO-1) in H9c2 cells. (F) Averaged 
densitometric quantiﬁcation of HO-1 protein levels. β-actin served as a loading control. (G) Effect of XML on the intracellular 
reactive oxygen species (ROS) production. ROS was determined by using DCFH-DA as a probe. Data was expressed as means 
± S.E.M. (n = 6). *P< 0.05, **P< 0.01, compared with Control. 
 
Discussion 
 
XML, as a TCM used for the treatment of CHF, shows a lot of therapeutic properties similar to those in western medicine. 
Clinically, XML is able to relieve the symptoms of CHF after a completed treatment for 15 d (Ma et al., 2013). The plasma 
angiotensin II level in patient with CHF is lowered after the XML treatment (Ma et al., 2013). Animal study also shows the 
enhancive effect of XML on the concentration of plasma prostacyclin (Yang et al., 2015). Since the elevation of PGI2 level is 
crucial in the management of pulmonary arterial hypertension (Buckley et al., 2013; Montani et al., 2014), which increases the 
afterload of the right ventricle and often induces the right-heart failure (Bogaard et al., 2009; Ryan et al., 2014), XML might 
exert its therapeutical effect not only on the left heart failure but also on the right heart failure. Meanwhile, these findings may 
also provide interpretations why XML also increases the flow of the coronary artery. 
XML also significantly enhances LVSP and LVEDP which is similar to cardiac glycosides and other positive inotropic 
drugs. However, most of the positive inotropic drugs are used to treat CHF target on L-type Ca
2+
 channels. β-adrenergic receptor 
agonists are good examples (Woo et al., 2012). β-adrenoceptors are coupled to Gs-proteins and then activate adenylyl cyclase. 
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The resulting increase in intracellular cyclic adenosine monophosphate (cAMP) activates protein kinase A (PKA) and then 
phosphorylates the L-type Ca
2+ 
channel. The activation of L-type Ca
2+ 
channels allow more Ca
2+ 
entering the cardiomyocytes. 
Another example is bipyridine such as milrinone. It acts by inhibiting phosphodiesterase IV, thereby increasing intracellular 
cAMP and then PKA which activates L-type Ca
2+ 
channels (Nagy et al., 2014). However, until now, there are no drugs targeting 
on the T-type Ca
2+ 
channels. T-type Ca
2+ 
channels are important in a wide variety of physiological functions such as hormone 
secretion, smooth muscle contraction, neuronal firing, cell proliferation of cardiac tissue and myoblast fusion (Vassort et al., 
2006; Perez-Reyes et al., 2003). In the cardiac tissues, T-type Ca
2+ 
channels are highly abundant in sinoatrial pacemaker cells 
and Purkinje fibers. They can maintain the pacemaker activity by setting the frequency of firing (Perez-Reyes et al., 2003). 
However, it was also found that T-type Ca
2+ 
channels are re-expressed in hypertrophied and failing ventricles. Increasing 
evidence has shown that T-type Ca
2+ 
channel may be related to the progression of CHF (Yasui et al., 2005; Chiang et al., 2009). 
Our data showed the effect of XML on potentiating the electrical impulse-induced increase in [Ca
2+
]i which is not dependent on 
intracellular Ca
2+ 
but dependent on extracellular Ca
2+ 
pool. This effect of XML was inhibited by T-type Ca
2+ 
channel blockers 
but not L-type Ca
2+ 
channel blockers. Our data indicates that XML may facilitate the T-type-dependent Ca
2+
 influx and enhance 
cardiac muscle contraction in CHF patients. More importantly, to the best of our knowledge, XML may be the first drug that 
targets on T-type Ca
2+
channels. 
In addition to the T-type Ca
2+
channels, our data also suggests that XML may also exert its positive inotropic effect through 
the inhibition of Na
+
/K
+
ATPase. This mechanism of action is similar to cardiac glycoside such as digoxin, which promotes 
Na
+
-Ca
2+ 
exchange via NCX, resulting in the Ca
2+ 
influx and increased myocardial contraction. Digoxin is the oldest drug used 
in clinical practice for treating CHF. However, there are a lot of limitations of using digoxin due to its complicated 
pharmacokinetic properties, narrow therapeutic index and high toxicity. Moreover, digoxin has parasympathomimetic action 
such the slowdown of the atrioventricular-nodal conduction
 
(Gheorghiade et al., 2006). Although the mechanism of action of 
XML involves the inhibition of Na
+
/K
+
-ATPase, which is similar to digoxin, XML has a potential to replace digoxin in clinical 
practice because several clinical studies have demonstrated the low toxicity and high therapeutic index of XML compared to the 
western drugs. Further investigations are required to study if XML may have significant interaction with other drugs. 
Free radicals and reactive oxygen species (ROS), such as hydrogen peroxide, superoxide anion, lipid peroxides 
(Blankenberg et al., 2003) may be the important factors leading to CHF because they deteriorate the decompensating 
myocardium (Keith et al., 1998; Prasad et al., 1996; Dieterich et al., 2000). Excess production of these free radicals and ROS 
can result in oxidative stress. The degree of oxidative stress directly correlates to the severity of subsequent myocardial damage 
(Shiomi et al., 2004). An increased ROS production results in apoptosis of cardiomyocytes, interstitial fibrosis, myocyte 
hypertrophy and myocardial ischemia and cardiac cell death. (Shiomi et al., 2004; Giordano 2005; Qiao et al., 2016). It has also 
been suggested that heart failure subsequent to myocardial infarction may be associated with antioxidant deﬁcit as well as 
increased myocardial oxidative stress (Khalid et al., 2014). It is worth mentioning that XML showed significant antioxidant 
effect in our study. XML significantly reduced ROS induced by H2O2 in H9c2 cells, and increase the expression of SOD-1, 
SOD-2, OH-1. Therefore, the antioxidant effect of XML might also play an important role in its therapeutic actions on CHF. 
However, since oxidative stress is a complex process, further investigations are also required to study the signaling pathways 
involved in the antioxidant effect of XML. 
 
Conclusions 
 
Our study has provided evidence that XML increase intracellular calcium level by activating T-type calcium channels and 
inhibiting Na
+
/K
+
-ATPase. The antioxidant effect of XML may also contribute to the cardioprotective effect of XML but further 
investigations are required. The antioxidant effect of XML may also contribute to the cardioprotective effect of XML but further 
investigations are required (Fig. 5). 
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Figure 5: Schematic diagram of the mechanisms underlying the action of XML in the treatment of heart failure. (A) 
XML may activate the T-type Ca
2+ 
channels which cause Ca
2+
 influx. In addition, its inhibitory effect on Na
+
-K
+
 ATPase causes 
an increase of [Na
+
]i, which would reverse the activity of sodium/calcium exchanger so that it pumps out Na
+ 
and pumps in Ca
2+ 
instead. As a result, [Ca
2+
]i is increased, which make the contraction force of the myocardium stronger and increase cardiac 
output to relieve the symptoms of CHF. (B) and (C) XML may also up-regulate the expressions of three antioxidant enzymes 
SOD-1, SOD-2 (B) and HO-1 (C). These pathways are supposed to be involved in ROS scavenging and confer the 
cardioprotective properties of XML. XML: Xinmailong Injection; NCX: sodium/calcium exchanger; SERCA: sacroplasmic 
reticulum Ca
2+
 ATPase; RYR2: ryanodine receptors type 2; SR: sarcoplasmic reticulum; SOD: superoxide dismutase; GPx: 
glutathione peroxidase; CAT: catalase; ER: endoplasmic reticulum; HO-1: hemeoxygenase-1. 
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